You are here: Industry Insights > Moderna

News List

Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline americanpharmaceuticalreview
May 28, 2021
Moderna a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing ...
India might get Moderna’s single-dose COVID-19 vaccine next year; Pfizer offers five crore shots in 2021 expresspharma
May 27, 2021
While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future.
Heart Issue Spotted in a Few Young COVID Vaccine Recipients drugs
May 25, 2021
A small number of teens and young adults have experienced heart inflammation after receiving mRNA COVID-19 vaccines produced by Pfizer and Moderna, the U.S. Centers for Disease Control and Prevention reports.
CDC Investigating Heart Problems in Teens, Young Adults After COVID-19 Vaccination drugs
May 25, 2021
Reports of myocarditis in a small number of teens and young adults who have received COVID-19 vaccines are being investigated by the U.S. Centers for Disease Control and Prevention.
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine prnasia
May 24, 2021
Moderna and Samsung Biologics announced a Manufacturing Services and Supply Agreement in which Samsung Biologics will provide large scale, commercial fill-finish manufacturing for mRNA-1273, Moderna's COVID-19 vaccine.
Moderna might manufacture COVID-19 vaccines in Japan expresspharma
May 24, 2021
Moderna Inc is considering manufacturing its COVID-19 vaccine in Japan, Nikkei newspaper reported, citing an interview with Stephane Bancel, the company’s CEO.
S Korea approves Moderna’s COVID-19 vaccine expresspharma
May 24, 2021
The green light comes after two of three expert panels recommended approval be granted for the two-dose vaccine based on safety and efficacy in late-stage trials in the United States.
Moderna, Samsung Biologics sign agreement for fill-finish manufacturing of COVID-19 vaccine expresspharma
May 24, 2021
The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish manufacturing service.
Highlights of the May 2021 Pharmacovigilance Risk Assessment Committee (PRAC) meeting europeanpharmaceuticalreview
May 11, 2021
In its May meeting, the EMA’s drug safety committee (PRAC) concluded two safety signal reviews for COVID-19 vaccines and began several more.
Moderna receives emergency use listing from WHO for Covid-19 vaccine pharmaceutical-technology
May 06, 2021
Moderna has received emergency use listing (EUL) from the World Health Organization (WHO) for its Covid-19 vaccine to prevent the disease in individuals aged 18 years and above.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page